Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Mar 10, 2015
    OPDP Untitled Letter Faults Company Over Comparison Graphic on Website
  • Mar 9, 2015
    OPDP Letter Blasts UCLA Over Alleged Investigational Drug Promotion
  • Mar 4, 2015
    Cross-center Crackdown Crushes Companies' Cannabis Claims
  • Mar 3, 2015
    S.C.: Johnson & Johnson Must Pay $136 Million Over Risperdal Claims
  • Feb 26, 2015
    Warning Letter Chides L’Oreal Over Drug-like Promotional Claims on Website for Cosmetics
  • Feb 26, 2015
    Two App Marketers Settle FTC Charges of Deceptive Marketing, Third Faces Suit
  • Feb 10, 2015
    First OPDP Untitled Letter of 2015 Tackles Claims in Cable Interview
  • Feb 9, 2015
    Guidance Pushes Consumer-friendly Risk Information for DTC Print Ads
  • Feb 2, 2015
    House Committee Pushes FDA To Allow Links to Risk Information in Online Ads
  • Jan 28, 2015
    Pfizer Looks to Settle Investor Suit Tied to Off-label Marketing for $400 Million
  • More

Good Clinical Practice

  • Jul 8, 2016
    CTTI Says Recruitment Planning Needs To Be Done Earlier
  • Jul 8, 2016
    OHRP Needs Workshop and Forum Co-sponsors
  • Jul 3, 2016
    FDA Issues Guidance on CMC Data for Early Trials with Live Biotherapeutics
  • Jul 2, 2016
    National Academies Report Details Proposed National Research Policy Board Responsibilities
  • Jul 1, 2016
    National Academies Panel Calls for New ‘Belmont’ Commission; Common Rule Revision Halt
  • Jun 24, 2016
    AAHRPP Accredits First Organizations in Africa and South America
  • Jun 24, 2016
    Researchers Report Online Trial Completed
  • Jun 23, 2016
    Cancer Support Community Launches Clinical Trial Education Program
  • Jun 22, 2016
    NIH Gets Ideas for Implementing Single IRB Review
  • Jun 22, 2016
    NIH Mandates Single IRB Review for U.S. Multi-site Research
  • More

FDA Regulation & Enforcement

  • Mar 5, 2019
    Appeals Court Remands Dietary Supplement Marketing Case To District Court
  • Mar 5, 2019
    Novartis Sues Janssen Over Advertising Claims
  • Mar 5, 2019
    OPDP Issues First Enforcement Letter for 2019
  • Mar 4, 2019
    FDA Emphasizes Product Communications
  • Mar 1, 2019
    Sales Rep Pleads Guilty Over Kickbacks
  • Feb 28, 2019
    Petition Asks for Dairy Labeling Enforcement, Offers FDA Regulatory Suggestions
  • Feb 27, 2019
    Device Maker Is Granted Summary Judgment in Dispute over Surgical Tool Info Provided Before Procedure
  • Feb 27, 2019
    Pennsylvania-Based Drug Maker To Pay $4 Million To Resolve Allegations That It Schemed To Avoid NDA User Fees
  • Feb 27, 2019
    TGA Improves Ad Complaint Database
  • Feb 27, 2019
    FTC Approves Final Order Over iV Cocktail Claims
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.